B. Barnaba

Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection.

J. Friedewald, R. Fontana, R. Chung, 2020, Journal of the American Society of Nephrology : JASN.

Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in an longitudinally sampled cohort of COVID-19 outpatients

S. Klein, R. Ursin, A. Pekosz, 2021, medRxiv.

Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C–Viremic Donors to Hepatitis C–Negative Recipients: An Open-Label Nonrandomized Study

D. Segev, M. Sulkowski, M. Chattergoon, 2020, Annals of Internal Medicine.

Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients

S. Klein, R. Ursin, A. Pekosz, 2021, Open forum infectious diseases.

Esophageal Cooling Device Versus Other Temperature Modulation Devices for Therapeutic Normothermia in Subarachnoid and Intracranial Hemorrhage

N. Badjatia, J. Haymore, Michael J. Armahizer, 2017, Therapeutic hypothermia and temperature management.